Equities

EDAP

US2683111072

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
7.28 ^USD	-1.62%		+0.28%	+37.88%

Apr. 26	European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	MT
Apr. 25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT

EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023

March 27, 2024 at 07:34 am EDT

EDAP TMS S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was EUR 60.42 million compared to EUR 55.11 million a year ago. Net loss was EUR 21.18 million compared to EUR 2.93 million a year ago.

Basic loss per share from continuing operations was EUR 0.57 compared to EUR 0.09 a year ago. Diluted loss per share from continuing operations was EUR 0.57 compared to EUR 0.09 a year ago.

Latest news about EDAP TMS S.A.

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	Apr. 26	MT
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	Apr. 25	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	Apr. 19	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	Apr. 04	MT
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	Apr. 01	MT
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	Mar. 27	MT
Transcript : EDAP TMS S.A., Q4 2023 Earnings Call, Mar 27, 2024	Mar. 27
EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
EDAP TMS S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 27	CI
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	Mar. 26	MT
EDAP TMS SA Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis	Mar. 04	CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	Mar. 01	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	Feb. 29	MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading	Feb. 27	MT
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading	Feb. 26	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	Feb. 21	MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading	Feb. 14	MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	Feb. 13	MT
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading	Feb. 09	MT
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading	Feb. 08	MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Friday Trading But End Week Higher	Feb. 02	MT
EDAP TMS S.A. Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One Hifu Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis	Feb. 01	CI
European Equities Traded in the US as American Depositary Receipts Trend Lower in Monday Trading	Jan. 29	MT
EDAP Names Ken Mobeck Global Finance Chief	Jan. 02	MT
EDAP TMS S.A. Appoints Ken Mobeck as Chief Financial Officer	Jan. 02	CI

Chart EDAP TMS S.A.

Duration

Period

More charts

Company Profile

Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-03 - American Urological Association Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for EDAP TMS S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.28 USD

Average target price

13.33 USD

Spread / Average Target

+83.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
EDAP TMS S.A.	+37.88%	270M
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
SIEMENS HEALTHINEERS AG	+0.65%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B

Other Advanced Medical Equipment & Technology